为了证明联合疫苗与单价疫苗等效性的临床试验，一个拒绝有区别的假设试验应

In order to prove the clinical trial of the equivalence of the combination vaccine and the monovalent vaccine, a hypothesis test that rejects distinction should be designed, rather than the indiscriminate "null" hypothesis test in the traditional sense.

To demonstrate the validity of clinical trials between combined vaccines and unit-price vaccines, a hypothetical trial that rejects a distinction should be designed, not a traditionally indesopoly indesoic "invalid" hypothesis trial.

In order to prove the equivalence of the combined vaccine and the monovalent vaccine, a hypothesis test that rejects the difference should be designed instead of the traditional undifferentiated "invalid" hypothesis test.<br>